The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of BioMarin Pharmaceutical (NasdaqGS:BMRN) with a ...

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...

These four blue chip stocks with dependable, high-yield dividends should continue to deliver regardless of inflation.

Robert F. Kennedy Jr., Trump's pick​ to lead the Department of Health and Human Services, has raised controversy on topics ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...

Trump's HHS pick could reshape public health agencies and usher in a new era for vaccines, food, and medicines.

Vaccines are most effective at scale when enough people get them to provide "herd immunity" from a virus, doctors and ...

The announcement that Robert F. Kennedy Jr. was chosen to be the next head of HHS raises many questions about his suitability ...

Similar processes are available around the world, with PRIME in the EU and SAKIGAKE designation in Japan, promoting early practical application for innovative pharmaceutical products, medical ...